110 related articles for article (PubMed ID: 11115733)
21. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
Arvanitis LA; Miller BG
Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
[TBL] [Abstract][Full Text] [Related]
22. Comparison of efficacy of a new butyrophenone derivative, timiperone and perphenazine in schizophrenia by a multicentre controlled study.
Takahashi R; Inanaga K; Samejima K; Sarai K; Asada S; Otsuki S; Nakano S
J Int Med Res; 1982; 10(4):257-67. PubMed ID: 6126413
[TBL] [Abstract][Full Text] [Related]
23. Double-blind comparison of bromperidol and perphenazine.
Woggon B; Angst J
Int Pharmacopsychiatry; 1978; 13(3):165-76. PubMed ID: 355182
[TBL] [Abstract][Full Text] [Related]
24. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
[No Abstract] [Full Text] [Related]
25. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
Maes M; De Meester I; Scharpe S; Desnyder R; Ranjan R; Meltzer HY
Acta Psychiatr Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8919323
[TBL] [Abstract][Full Text] [Related]
26. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
Galinowski A; Poirier MF; Aymard N; Leyris A; Beauverie P; Bourdel MC; Loo H
Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519
[TBL] [Abstract][Full Text] [Related]
27. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.
Bartlett EJ; Brodie JD; Simkowitz P; Schlösser R; Dewey SL; Lindenmayer JP; Rusinek H; Wolkin A; Cancro R; Schiffer W
Am J Psychiatry; 1998 Mar; 155(3):337-43. PubMed ID: 9501742
[TBL] [Abstract][Full Text] [Related]
28. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
Bernardo M; Parellada E; Lomeña F; Catafau AM; Font M; Gómez JC; López-Carrero C; Gutiérrez F; Pavía J; Salamero M
Psychiatry Res; 2001 Aug; 107(2):87-97. PubMed ID: 11530275
[TBL] [Abstract][Full Text] [Related]
29. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.
Zhang XY; Zhou DF; Cao LY; Wu GY
Psychopharmacology (Berl); 2006 Sep; 188(1):12-7. PubMed ID: 16906395
[TBL] [Abstract][Full Text] [Related]
30. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L
Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
[TBL] [Abstract][Full Text] [Related]
33. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
Spivak B; Shabash E; Sheitman B; Weizman A; Mester R
J Clin Psychiatry; 2003 Jul; 64(7):755-60. PubMed ID: 12934974
[TBL] [Abstract][Full Text] [Related]
34. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
35. Olanzapine and haloperidol for residual symptoms.
de Haan L; van Beveren N
Am J Psychiatry; 2005 Jul; 162(7):1392-3; author reply 1393. PubMed ID: 15994737
[No Abstract] [Full Text] [Related]
36. A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.
Emsley RA; Raniwalla J; Bailey PJ; Jones AM
Int Clin Psychopharmacol; 2000 May; 15(3):121-31. PubMed ID: 10870870
[TBL] [Abstract][Full Text] [Related]
37. The CATIE schizophrenia effectiveness trial.
Delisi LE; Nasrallah HA
Schizophr Res; 2005 Dec; 80(1):v-vi. PubMed ID: 16291292
[No Abstract] [Full Text] [Related]
38. Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats.
Arad M; Weiner I
Psychoneuroendocrinology; 2012 Feb; 37(2):200-12. PubMed ID: 21723667
[TBL] [Abstract][Full Text] [Related]
39. Cross-over comparison of the therapeutic effects of sulpiride and perphenazine in schizophrenic and schizoaffective psychoses.
Svestka J; Rysánek R; Cesková E; Náhunek K
Act Nerv Super (Praha); 1989 Apr; 31(1):35-6. PubMed ID: 2571220
[No Abstract] [Full Text] [Related]
40. Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients.
Vallabhajosula S; Hirschowitz J; Machac J
J Nucl Med; 1997 Feb; 38(2):203-7. PubMed ID: 9025736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
